Docosahexaenoic Acid on Breath Holding Spells in Children

Breath Holding Attack Clinical Trial

Official title:

Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03965988
• Other study ID #: breah holding
• Status: Recruiting
• Phase: Phase 3
• Start date: May 1, 2018
• Est. completion date: December 2028

Study information

• Verified date: May 2019
• Source: Tanta University
• Contact: Sherief Abd-Elsalam, ass. prof.
• Phone: 00201147773440
• Email: sheriefabdelsalam[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

DHA on Breath Holding Spells

Description:

Effect of DHA on Breath Holding Spells

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: December 2028
• Est. primary completion date: November 2028
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Month to 5 Years

Eligibility

Inclusion Criteria:

• Children with newly diagnosed sprlls

Exclusion Criteria Other treatment as iron and piracetam

Related Conditions & MeSH terms

• Breath Holding Attack

Intervention

Drug:
• DHA
Docosahexaenoic acid
• Placebo
Placebo

Locations

Country	Name	City	State
Egypt	Sherief Abd-Elsalam	Tanta

Sponsors (1)

Lead Sponsor	Collaborator
Sherief Abd-Elsalam

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Frequency of the spells	Number of attacks	6 months